Skip to content
Open access

Low-density lipoprotein cholesterol modulates amyloid-related entorhinal vulnerability and episodic memory performance in older adults

Sep 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 34 references

TL;DR

Circulating LDL-C was associated with modest heterogeneity in the cross-sectional Aβ–EC relationship, with more clearly negative conditional associations observed at higher LDL-C levels, and a similar interaction was observed for non-HDL cholesterol, suggesting that the pattern may reflect a broader atherogenic lipid context.

Abstract

Cerebral amyloid-beta (Aβ) burden does not fully explain variation in Alzheimer’s disease (AD)-related brain structure and episodic memory. We examined whether circulating low-density lipoprotein cholesterol (LDL-C) modifies the cross-sectional statistical association between Aβ burden, the entorhinal cortex (EC) thickness and episodic memory performance. Cross-sectional data from 1,253 individuals in the Gwangju Alzheimer’s Disease and Related Dementias cohort (798 cognitively normal, 425 mild cognitive impairment, 30 AD dementia) were analyzed. Primary conditional-process models were adjusted for age, sex, education, body mass index, and HbA1c; clinical diagnosis was examined in sensitivity analyses. HC3 heteroskedasticity-consistent inference was used for the focal interaction, and indirect associations were estimated using 10,000 bootstrap resamples. Greater Aβ burden was associated with lower EC thickness (β = −0.0863, p = 0.0012), and EC thickness was positively associated with episodic memory (β = 0.3809, p < 0.001). The unconditional indirect statistical association was supported (β = −0.0329, 95% bias-corrected bootstrap CI [−0.0647, −0.0072]). LDL-C modified the Aβ–EC association (β = −0.0937, HC3 SE = 0.0332, 95% CI [−0.1589, −0.0285], p = 0.0049), although the incremental explanatory magnitude was small (ΔR 2 = 0.0082). The conditional Aβ–EC association was unsupported at approximately 66 mg/dL LDL-C (β = 0.0263, p = 0.583), not statistically supported at approximately 100 mg/dL (β = −0.0639, p = 0.060), and negative at 138 mg/dL (β = −0.1648, p < 0.001). The index of moderated indirect association was supported (β = −0.0357, 95% bias-corrected bootstrap CI [−0.0637, −0.0119]); conditional indirect associations were most clearly supported at higher LDL-C levels. A similar interaction was observed for non-HDL cholesterol, suggesting that the pattern may reflect a broader atherogenic lipid context. Circulating LDL-C was associated with modest heterogeneity in the cross-sectional Aβ–EC relationship, with more clearly negative conditional associations observed at higher LDL-C levels. Longitudinal studies are needed to determine the temporal and clinical relevance of these findings.

Read PDF

Similar papers

Open access Jul 2026

APOE and amyloid‐tau pathology in cognitively unimpaired older adults

Abstract INTRODUCTION Apolipoprotein E (APOE) genotype shows well‐established dose‐dependent associations with higher amyloid in cognitively unimpaired (CU) adults. In contrast, associations with tau burden and cognition are less well characterized. METHODS We performed a cross‐sectional analysis of CU participants fro...

Carlos Albarrán Morillo, Lu-Kai Zheng, E. Ghanbarian et al. · 0 citations
Sep 2026

Associations of plasma lipid burden with cognitive performance and decline across dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia.

BackgroundPeripheral lipid dysregulation has been implicated in neurodegeneration, but most studies have focused on single lipid measures within one dementia subtype.ObjectiveTo determine whether a composite plasma lipid burden score (PLBS), derived from routine fasting lipid indices, differs across dementia with Lewy...

Zhou Su, Meng-Ran Liu, Li Su et al. · 0 citations
Sep 2026

APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults.

BackgroundSleep disturbance has been linked to Alzheimer's disease (AD), but whether its relationships with cerebral amyloid-β (Aβ) pathology and clinical progression are modified by APOE ε4 (APOE4) carrier status in cognitively normal elderly remains unclear.ObjectiveTo examine APOE4 moderation of the associations of...

Min-Ji Lee, Ji-Hyun Kim, H. Choi et al. · 0 citations
Open access Jul 2026

Linking cognitive variability and Alzheimer's disease biomarkers by neurocognitive status

Abstract INTRODUCTION This study aimed to assess intra‐individual cognitive variability (IICV) in relation to Alzheimer's disease (AD) biomarkers. METHODS The National Alzheimer's Coordinating Center sample (n = 879), aged 50+ with a complete neuropsychological evaluation and AD biomarker data available (64% cognitivel...

S. S. Lin, Alicia L. Milam, Andrew Kiselica et al. · 0 citations
Open access Jul 2026

Parallel neuroinflammatory pathways to cerebrovascular burden and amyloid beta in Alzheimer's disease

Higher plasma YKL‐40 was associated with greater white matter hyperintensity (WMH), whereas higher plasma GFAP was related to increased 18F‐florbetapir (FBP) standardized uptake value ratio (SUVR) and higher plasma p‐tau217 was associated with reduced MTL cortical thickness and hippocampal volume.

Batool Rizvi, Jenna N. Adams, Alison R. Bamford et al. · 1 citation
Sep 2026

Lower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participants.

Both serum serotonin and cardiovascular-risk (CVR) burden are implicated in Alzheimer's disease (AD)-related vascular and neurodegenerative processes, yet their interrelationship across the AD continuum remains unclear. This cross-sectional study examined whether serum serotonin was associated with three complementary...

N. F. Alreshidi, Saeed A. Al-Qahtani, Kholoud S. Almasoudi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.